CrossrefInfokarte
Gustave Roussy immune score is an independent prognostic factor for treatment response and survival in advanced non-small cell lung cancer treated with nivolumab at second-line therapy
Oncology in Clinical Practice · 2025
DOI: 10.5603/ocp.101103 ↗Abstract
Kein Abstract verfügbar.
EUVIMED